Azacitidine with or without eltrombopag for first-line treatment of intermediate- or high-risk MDS with thrombocytopenia
Dickinson, M., Cherif, H., Fenaux, P., Mittelman, M., Verma, A., Portella, M. S. O., Burgess, P., Ramos, P. M., Choi, J., Platzbecker, U., on behalf of the SUPPORT study investigators
American Society of Hematology (ASH)
Published 2018
American Society of Hematology (ASH)
Published 2018
Publication Date: |
2018-12-21
|
---|---|
Publisher: |
American Society of Hematology (ASH)
|
Print ISSN: |
0006-4971
|
Electronic ISSN: |
1528-0020
|
Topics: |
Biology
Medicine
|
Keywords: |
Myeloid Neoplasia, Clinical Trials and Observations
|
Published by: |